IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 51 filers reported holding IGM BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,515,058 | +16.8% | 900,007 | +29.1% | 0.00% | – |
Q2 2023 | $6,435,968 | -19.3% | 697,288 | +20.1% | 0.00% | – |
Q1 2023 | $7,974,174 | -18.8% | 580,362 | +0.6% | 0.00% | – |
Q4 2022 | $9,817,611 | -17.0% | 577,167 | +11.0% | 0.00% | – |
Q3 2022 | $11,824,000 | +28.3% | 519,977 | +1.8% | 0.00% | – |
Q2 2022 | $9,213,000 | -58.5% | 510,933 | -38.4% | 0.00% | -100.0% |
Q1 2022 | $22,188,000 | +82.3% | 830,077 | +100.0% | 0.00% | – |
Q4 2021 | $12,173,000 | -55.1% | 415,049 | +0.6% | 0.00% | -100.0% |
Q3 2021 | $27,131,000 | -20.4% | 412,559 | +0.7% | 0.00% | 0.0% |
Q2 2021 | $34,096,000 | +10.0% | 409,803 | +1.4% | 0.00% | 0.0% |
Q1 2021 | $30,989,000 | -20.4% | 404,101 | -8.4% | 0.00% | 0.0% |
Q4 2020 | $38,930,000 | +41.8% | 440,931 | +18.6% | 0.00% | 0.0% |
Q3 2020 | $27,446,000 | -20.3% | 371,854 | -21.2% | 0.00% | 0.0% |
Q2 2020 | $34,447,000 | +22.7% | 471,872 | -5.6% | 0.00% | 0.0% |
Q1 2020 | $28,069,000 | +45.7% | 499,879 | -1.0% | 0.00% | 0.0% |
Q4 2019 | $19,259,000 | +4247.4% | 504,681 | +1918.7% | 0.00% | – |
Q3 2019 | $443,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |